EntrepreneurialCheck
Harry Clifford estimated net worth profile

Harry Clifford net worth

Harry Clifford Net Worth 2026 (Estimated) · CTO at Cambridge Cancer Genomics · YC S17
est. wealth $19K

Quick answer

Harry Clifford's estimated net worth is $19K (range $13K – $28K) as of 2026. Harry Clifford is CTO at Cambridge Cancer Genomics. Cambridge Cancer Genomics valuation.

Harry Clifford is CTO at Cambridge Cancer Genomics (YC S17). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameHarry Clifford
RoleCTO
CompanyCambridge Cancer Genomics
YC batchS17
Est. company val$1.0M
Assumed ownership1.9%
Est. paper wealth / net worth$19K
$13K – $28K
  • Company status: Inactive
  • Education: University of Cambridge
  • Region: United Kingdom
  • Industries: Healthcare, Diagnostics
  • Team size: 25
  • Website: http://ccg.ai

Who is Harry Clifford?

Harry Clifford is a co-founder of Cambridge Cancer Genomics, a company focused on advancing cancer diagnostics through genomics.

Highlights:

  • University of Cambridge
  • Cambridge Cancer Genomics
  • Y Combinator S17

About Cambridge Cancer Genomics

CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. ‍ We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions...

FAQ: Harry Clifford net worth and Cambridge Cancer Genomics valuation

What is Harry Clifford's net worth?

Harry Clifford's estimated net worth is $19K (range $13K – $28K) as of 2026. Harry Clifford is CTO at Cambridge Cancer Genomics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Cambridge Cancer Genomics valuation?

Cambridge Cancer Genomics's estimated valuation on Entrepreneurial Check is $1.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Harry Clifford's role?

Harry Clifford is CTO at Cambridge Cancer Genomics, a Y Combinator-backed startup (batch S17).